The Securities Appellate Tribunal (SAT) has quashed the charges of insider trading in Biocon against Shreehas Tambe, president and deputy CEO of Biocon Biologics. Sebi had passed an order restraining Tambe from accessing the securities market for a period of three months and also restraining him from associating with any listed public company or any …
